Public signalCompany raiseAuto-indexed · Unverified
Kestrel Therapeutics Inc. raised $5.0M
Kestrel Therapeutics Inc.· Boston, US· Biotechnology· Filed Aug 12, 2025
Kestrel Therapeutics Inc. reported raising capital. Based in Boston, MASSACHUSETTS, US. First sale reported 2025-07-28. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$5.0M
Confidence90%
On the record
- Location
- Boston, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $5.0M
- Target amount
- $10.0M
- Filing date
- Aug 12, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 5,000,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Aug 12, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$1M – $10MCompany Raise
Are you associated with Kestrel Therapeutics Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record